Presenters

Meghan A. Coghlan, MD, Attending Physician, Neonatology, Ann & Robert H. Lurie Children’s Hospital of Chicago; Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Disclosure: Dr. Coghlan has no industry relationships to disclose and does not refer to products that are still investigational or not labeled for the use in discussion 

Target Audience

Primary Care Providers

Objectives

At the conclusion of this activity, participants will be able to:

• Discuss risk factors for hyperbilirubinemia
• Discuss recommended treatment strategies
• Describe the recommended pathway for escalation of care

Release Date: 5/8/2023

CME quiz must be taken before 5/8/2024 to receive credit.

How to Earn Credit

1. Click on the green "View Online" in the right-hand column (you will be prompted to log in)
2. Next, click on the "Start" or "View Now" button to view/read the article.
3. Once you have read the article, "X" out of the window to return to this page.
4. Click on the blue "Submit for Credit" button.
5. Complete the evaluation and quiz.

Accreditation & Credit Statements

Accreditation Statement: The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement: The Northwestern University Feinberg School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
 

CME Office and Review Committee Disclosures

In accordance with ACCME Standards for Commercial Support of Continuing Medical Education and the Feinberg School of Medicine’s disclosure policy for CME activities, all individuals who contribute to the content or the identification / resolution of potential conflicts of interest must disclose any relationship they may have with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients within the preceding 12 months of the activity.  Such disclosure is intended to provide participants with sufficient information to evaluate whether any given presentation has been influence by the faculty’s relationships(s) or financial interest with said companies.  

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.  The purpose for identifying and addressing potential conflicts of interest is to ensure a proper balance, independence, objectivity and scientific rigor of the medical school’s educational activities. The medical school does not view the existence of a financial relationship as necessarily implying bias or decreasing the value of participation in CME activities, but must ensure that a financial interest is not a conflict of interest.  Identifying Conflict of Interest:  A six-tier peer review system has been developed to identify possible conflicts of interests.  

1. The first tier is the Speaker
2. The second-tier is the Course Director and/or Planning Committee Members
3. The third-tier is the CME Manager
4. The fourth-tier is the CME Review Committee
5. The fifth-tier is the CME Medical Director
6. The sixth-tier is the CME Coordinator

Feinberg School of Medicine's CME Leadership and Staff

• Clara Schroedl, MD, Medical Director of CME. Has nothing to disclose.
• Sheryl Corey, CME Manager. Has nothing to disclose.
• Allison McCollum, Senior Program Coordinator. Has nothing to disclose.
• Katie Daley, Senior Program Coordinator. Has nothing to disclose.
• Michael John Rooney, Senior RSS Program Coordinator. Has nothing to disclose.
• Rhea Alexis Banks, Administrative Assistant 2. Has nothing to disclose.

Course Director’s and Planning Committee Members Disclosure Information:

• Dr. Ravi Jhaveri, Course Director, Lurie Children's, has disclosed engagement in activities such as speaking, advising, consulting, or providing educational programs for the following companies or other entities: AstraZeneca, Dynavax Technologies, Elsevier Journals, Seqirus. All relevant financial relationships for this individual have been mitigated.
• Vita Lerman, Editor, Lurie Children’s, has nothing to disclose.

To contact the FSM CME office, please call 312.503.8533 or email cme@northwestern.edu
To contact the course director and planning group at Lurie Children’s, please call 312.227.4263 or email vlerman@luriechildrens.org